Form 4: Eli Lilly Director Juan R. Luciano Acquires Shares Through Deferral Plan
SEC Form 4 Filing
Director Juan R. Luciano of Eli Lilly & Co. acquired shares through a deferral plan, increasing his holdings.
Summary
- Juan R. Luciano, a director at Eli Lilly & Co., acquired 20.398 shares of common stock at a price of $727.2 per share on November 18, 2024.
- These shares were acquired as part of the Lilly Directors' Deferral Plan, where the shares are deferred in lieu of cash compensation.
- Additionally, Mr. Luciano acquired 302.53 shares of common stock at the same price on the same date.
- Following these transactions, Mr. Luciano's direct holdings increased to 16,146.533 shares.
- The shares acquired through the deferral plan will be settled in shares of common stock after Mr. Luciano's separation from service.
Sentiment
Score: 7
Explanation: The document reflects a routine transaction related to director compensation, which is generally viewed neutrally to positively. The acquisition of shares by a director can be seen as a positive sign of confidence in the company.
Positives
- The acquisition of shares by a director can be seen as a positive sign of confidence in the company's future.
- The deferral plan allows for long-term alignment of interests between the director and the company.
Future Outlook
The deferred shares will be settled in shares of common stock following the reporting person's separation from service.
Industry Context
This is a routine filing related to director stock ownership and is common practice for publicly traded companies. It reflects standard compensation practices for board members.
Comparison to Industry Standards
- Director share acquisitions through deferral plans are a common practice among publicly traded companies, including pharmaceutical companies like Pfizer (PFE) and Merck (MRK).
- These plans are often used to align the interests of directors with the long-term performance of the company.
- The specific terms of deferral plans can vary, but the general concept of deferring compensation into company stock is widely used.
Stakeholder Impact
- The increase in director share ownership can be viewed positively by shareholders as it aligns the director's interests with those of the shareholders.
Key Dates
| Date | Description |
|---|---|
| 11/18/2024 | Date of the share acquisition transactions. |
| 11/20/2024 | Date the form was signed. |
Keywords
Eli Lilly, Director, Share Acquisition, Deferral Plan, Stock Ownership, Juan R. Luciano, LLY
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.